Physician

Marc Douglas Shields, MD

According to 2025 Medicare claims, Marc Shields, MD (NPI: 1265435226) practices ophthalmology in the Staunton-Stuarts Draft, VA market, with the plurality of this provider's patient population coming from Staunton City, VA. This provider's primary affiliated billing organization is EYE ONE, PLC (NPI: 1982613576; TIN: 541738160) and primary practice location at 24401-9032. Shields is affiliated with the Augusta Care Partners, LLC (ACO ID: A2266), participating under the MSSP model.

Shields' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,897 traditional Medicare patients, billed 5,938 HCPCS/CPT codes, and received $313,131 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,677 prescription claims across 623 beneficiaries totaling $39,241 in drug costs, led by Latanoprost (Latanoprost). Open Payments data shows 12 records totaling $190. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$189K$377K2015 Medicare payment: $330,721 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $336,509 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $354,764 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $358,674 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $377,361 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $279,660 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $327,200 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $318,485 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $299,958 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $313,131 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,7725,366$330,721
20161,8575,905$336,509
20171,9625,932$354,764
20182,0365,960$358,674
20192,0245,923$377,361
20201,8324,770$279,660
20211,9675,754$327,200
20221,9325,658$318,485
20231,8655,357$299,958
20241,8975,938$313,131

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$30K$59K2015 Drug cost: $43,727 (USD; Tot_Drug_Cst)2016 Drug cost: $48,201 (USD; Tot_Drug_Cst)2017 Drug cost: $52,057 (USD; Tot_Drug_Cst)2018 Drug cost: $56,904 (USD; Tot_Drug_Cst)2019 Drug cost: $59,109 (USD; Tot_Drug_Cst)2020 Drug cost: $55,153 (USD; Tot_Drug_Cst)2021 Drug cost: $56,227 (USD; Tot_Drug_Cst)2022 Drug cost: $40,373 (USD; Tot_Drug_Cst)2023 Drug cost: $53,651 (USD; Tot_Drug_Cst)2024 Drug cost: $39,241 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153491,009$43,727
20163551,026$48,201
20174421,201$52,057
20184011,239$56,904
20194711,397$59,109
20204381,260$55,153
20215301,545$56,227
20225301,563$40,373
20235161,522$53,651
20246231,677$39,241

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,1361,179$78
92012Established patient problem focused exam of visual system380442$61
92083Exam of visual field with extended testing291307$45
92133Imaging of optic nerve244252$24
92285Photography of content of eyes248265$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LatanoprostLatanoprost83747,272$7,159
ErythromycinErythromycin Base3864,998$3,351
BrinzolamideBrinzolamide15760$3,112
Prednisolone AcetatePrednisolone Acetate22969$2,038
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat643,684$1,452

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$190Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marc Douglas Shields, MD?

Tedicare shows public-source Medicare data for Marc Douglas Shields, MD (NPI 1265435226), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc Douglas Shields, MD have ACO affiliation data?

Marc Douglas Shields, MD is shown with ACO affiliation data for Augusta Care Partners, LLC (MSSP, ACO ID A2266).

What billing organization is linked to Marc Douglas Shields, MD?

Marc Douglas Shields, MD is linked to EYE ONE, PLC (billing NPI 1982613576) in the available physician profile data.

Does Marc Douglas Shields, MD have Open Payments data?

Marc Douglas Shields, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.